How to Ask HR About GLP-1 Coverage Without Disclosing Your Health Plans

Why This Conversation Feels Harder Than It Should

You want to know whether your employer's health plan covers GLP-1 medications. That's a straightforward benefits question. But weight is personal, and asking about obesity treatment can feel like revealing more than you want to share with your workplace.

The good news: you don't have to share anything personal. Benefits questions are part of HR's core function, and you can frame this inquiry in ways that reveal nothing about your own health status. Here's how.

The Three Approaches That Work

Approach 1: The General Benefits Inquiry

Email or call your HR benefits contact and say: "I'm reviewing our health plan benefits and wanted to ask whether anti-obesity medications like Wegovy or Zepbound are included on the formulary. Where can I find the current formulary document?"

This frames it as a benefits literacy question, not a personal health question. You're asking about what's available, not requesting access.

Approach 2: The Competitive Benchmark

If your employer is actively competing for talent, you can frame it forward-looking: "I noticed several employers in our industry have added GLP-1 coverage as a benefit this year. Has our plan committee discussed this? I think it would be a valued addition."

This positions you as someone interested in the company's competitive benefits package rather than someone seeking personal treatment.

Approach 3: Skip HR Entirely

Call the number on the back of your insurance card directly. You're calling your insurance company — not your employer. Ask the customer service representative: "Is semaglutide or tirzepatide on my plan's formulary? And what are the prior authorization requirements?"

This bypasses your employer completely. Your insurer can tell you exactly what's covered, what's excluded, and what documentation you'd need for approval.

What HIPAA Actually Protects (and What It Doesn't)

A common concern: "If I start taking a GLP-1 through my employer plan, will my employer find out?" The short answer is no — with important nuances.

HIPAA prohibits your health plan from sharing your individual protected health information (PHI) with your employer. Your HR department may administer the plan, but plan administrators who handle enrollment and eligibility cannot access individual claims data unless they're also part of the plan's covered entity — and even then, there are strict firewalls.

What your employer can see is aggregate data: total plan spending on a drug category, total number of claimants using anti-obesity medications (without names), and overall utilization trends. In a very small company (under 20 employees), aggregate data could theoretically narrow down who's using what — but the legal protections remain the same.

Your pharmacy benefits manager (PBM) processes your prescription. Your employer sees a line item in their aggregate claims report. They do not see your name attached to that line item.

If the Answer Is 'No Coverage': Your Next Move

If your plan doesn't cover GLP-1s for weight management, you have three immediate paths forward:

Path 1: Appeal through your prescriber. Even without explicit formulary coverage, your prescriber can request a formulary exception based on medical necessity. This works when you have documented comorbidities that make GLP-1 treatment clinically appropriate.

Path 2: Manufacturer savings programs. Both Novo Nordisk and Eli Lilly offer savings cards and patient assistance programs that can reduce brand-name costs to $0-$25/month for commercially insured patients, even when the plan doesn't cover the medication directly.

Path 3: Cash-pay compounded. Licensed telehealth platforms offer compounded semaglutide and tirzepatide at $149-$399/month without any insurance involvement. These are not FDA-approved but are legally prescribed by licensed providers using medications from licensed compounding pharmacies.